Abbott Labs Pfizer: Which Is the Bigger Value Trap Now
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Nearing retirement at 50? Discover wealth management strategies tailored to secure your financial future effectively.
21,324 articlesAbbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Aurora Innovation saw a dramatic rally in the first half of 2026. This article explores the factors behind the move, ...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
China’s Kimi K3 arrives in the crypto AI arena with benchmark wins that outpace Claude Fable and GPT 5.6 Sol. This ar...
A leading XRPL validator announced opposition to additional reserve reductions, reviving a divide in the community ov...
Agentic AI could automate payments and settlements in crypto, but it needs solid blockchain rails. This piece breaks ...
DBA closed $68 million for its second venture fund on Feb. 18, 2026, signaling sustained appetite for crypto infrastr...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
Oil States International (OIS) faces a shifting offshore market as 2025 unfolds. This guide breaks down the likely dr...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Keurig Dr Pepper reported stronger-than-expected Q4 results and unveiled an $18 billion deal to acquire JDE Peet's, p...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...